261/521US=33 / Gastro
Jacobs ET, Thompson PA, Martínez ME. Enviromental and lifestyle issues in colorectal cancer. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 511-26. ISBN 978-0-7817-7617-2.

CANCER COLORRETAL; QUESTOES AMBIENTAIS; ESTILO DE VIDA; EPIDEMIOLOGIA; ADENOMA COLORRETAL

262/521US=33 / Gastro
Levin B. Colorectal cancer: screening and surveillance. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 527-38. ISBN 978-0-7817-7617-2.

CANCER COLORRETAL; TRIAGEM; VIGILANCIA

263/521US=33 / Gastro
Grady WM. Colorectal cancer: molecular biology and genetics. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 539-53. ISBN 978-0-7817-7617-2.

CANCER COLORRETAL; BIOLOGIA MOLECULAR; GENETICA

264/521US=33 / Gastro
Smyrk TC. Colorectal cancer: pathology. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 555-65. ISBN 978-0-7817-7617-2.

CANCER COLORRETAL; PATOLOGIA; CARCINOMA COLORRETAL

265/521US=33 / Gastro
Chin ID, Paun BC. Colorectal cancer: anatomy and staging. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 567-79. ISBN 978-0-7817-7617-2.

CANCER COLORRETAL; INTESTINO GROSSO. ANATOMIA; CANCER COLORRETAL. ESTADIAMENTO; ULTRASOM ENDORETAL

266/521US=33 / Gastro
Saltz LB. Systemic therapy for metastatic colorectal cancer. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 617-30. ISBN 978-0-7817-7617-2.

CANCER COLORRETAL METASTATICO; TERAPIA SISTEMICA; QUIMIOTERAPIA CITOTOXICA; AGENTE RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO

267/521US=33 / Gastro
Taleb P, Nordlinger B. Colorectal cancer: surgery and local ablation of liver metasteses. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 631-7. ISBN 978-0-7817-7617-2.

CANCER COLORRETAL; CIRURGIA; ABLACAO; METASTASE HEPATICA; RESSECCAO DE METASTASES HEPATICAS; CIRURGIA

268/521US=33 / Gastro
Zelenetz AD. Lymphomas of the gastrointestinal tract. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 671-92. ISBN 978-0-7817-7617-2.

LINFOMA; TRATO GASTROINTESTINAL; LINFOMA MALT GASTRICO; LINFOMA COLORRETAL; INTESTINO DELGADO

269/521US=3-B / Clín/Médica
Mayer RJ. Câncer do trato gastrintestinal. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 570-80. ISBN 85-7726050-8.

CANCER DO TRATO GASTRINTESTINAL; CANCER ESOFAGICO; TUMORES DO ESTOMAGO; ADENOCARCINOMA GASTRICO; LINFOMA GASTRICO PRIMARIO; CANCER COLORRETAL; TUMORES DO INTESTINO DELGADO; CANCERES DO ANUS

270/521Câncer
Torres N, Amaral FC, Oliveira EB, Saggioro FP, Rocha JR, Feres O, Silva Jr. WA, Oliveira RB, Castro M. Differential expression of miR-143, miR-145 and miR-150 in colorectal cancer. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.4, p. 116-21, 2011. ISSN 1980-5578.

Disponível em: http://accamargo@.phlnet.com.br/applied/ACR2011;31p.116-21.pdf

CANCER COLORRETAL; EXPRESSAO GENICA; MICRORNAS

271/521US=3-G / Patologia
Kumar V, Abbas AK, Fausto N, Mitchell RN. Cavidade oral e trato gastrointestinal. In: ___. Robbins patologia básica. 8ª ed. Rio de Janeiro: Elsevier, 2008. p. 631-87. ISBN 85-3522729-1.

ULCERA AFTOSA RECORRENTE; AFTA; INFECCAO POR HERPESVIRUS; CANDIDASE ORAL; AIDS; SARCOMA DE KAPOSI; LEUCOPLASIA; ERITROPLASIA; NEOPLASIA ORAL; DOENCAS DAS GLANDULAS SALIVARES; SIALODENITE; TUMORES DAS GLANDULAS SALIVARES; LESOES DO ESOFAGO; ACALASIA; HERNIA DE HIATO; SINDROME DE MALLORY-WEISS; VARIZES; ESOFAGITE; ESOFAGO DE BARRETT; CARCINOMA ESOFAGICO; GASTRITE; ULCERACAO GASTRICA; ULCERA PEPTICA; ULCERA GASTRICA; POLIPO GASTRICO; CARCINOMA GASTRICO; DOENCA DE HIRSCHSPRUNG; DOENCA INTESTINAL ISQUEMICA; ANGIODISPLASIA; HEMORROIDA; DIVERTICULITE COLONICA; OBSTRUCAO INTESTINAL; ENTEROCOLITE; SINDROME DE MA ABSORCAO; DOENCA INTESTINAL INFLAMATORIA; DOENCA DE CROHN; COLITE ULCERATIVA; TUMORES DO INTESTINO; POLIPO NAO-NEOPLASICO; ADENOMA; SINDROME DE POLIPOSE FAMILIAR; CARCINOMA COLORRETAL; NEOPLASIA DO INTESTINO DELGADO; TUMORES ESTROMAIS GASTROINTESTINAIS; LINFOMAS GASTROINTESTINAIS; CARCINOIDES; APENDICITE AGUDA; TUMORES DO APENDICE

272/521US=4 / Câncer
Lago S. Prevenção e quimioprevenção em oncologia. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 68-70. ISBN 85-3631168-5.

ONCOLOGIA. PREVENCAO; CANCER DE PULMAO; CANCER DE CABECA E PESCOCO; CANCER DE PELE; CANCER DE PROSTATA; CANCER DE MAMA; CANCER COLORRETAL

273/521US=433 / Tese/FAP
Costa AC. Impacto da expressão de fatores relacionados a hipóxia (HIF1A e VEGF) e metabolismo lipídico (LXRA, LXRB e PPARG) em tumores de cólon estádio clínico II e III). [Impact of expression of factors related to hypoxia (HIF1A and VEGF) and lipid metabolism (LXRA, LXRB and PPARG) in colon cancer clinical stage II and III]. São Paulo, 2012. 80 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/AdrianoCarneiro/AdrianoCarneiro.pdf

Curriculum Lattes

NEOPLASIAS DO COLO; CANCER DE COLON; HIPOXIA; FATOR 1 INDUZIVEL POR HIPOXIA; FATORES DE CRESCIMENTO DO ENDOTELIO VASCULAR; LIPIDEOS. METABOLISMO

274/521US=44 / Gastro
Moayyedi P. Epidemiology and prevention of colorectal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 293-304. ISBN 978-1-4051-2783-7.

CANCER COLORRETAL. EPIDEMIOLOGIA; CANCER COLORRETAL. PREVENCAO

275/521US=44 / Gastro
Pignatelli M, Banu N, Melegh Z. The molecular pathology of sporadic and hereditary colorectal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 305-16. ISBN 978-1-4051-2783-7.

CANCER COLORRETAL HEREDITARIO; PATOLOGIA MOLECULAR; POLIPOSE ADENOMATOSA FAMILIAR; CANCER COLORRETAL ESPORADICO; CANCER COLORRETAL HUMANO NAO-POLIPOSE

276/521US=44 / Gastro
Steele RJC. Screening for colorectal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 317-24. ISBN 978-1-4051-2783-7.

CANCER COLORRETAL. RASTREIO; EXAME DE SANGUE OCULTO NAS FEZES; SIGMOIDOSCOPIA FLEXIVEL; COLONOSCOPIA; RADIOLOGIA

277/521US=44 / Gastro
Midgley RS. Cancer of the colon and rectum. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 325-73. ISBN 978-1-4051-2783-7.

CANCER COLORRETAL. DIAGNOSTICO; CANCER COLORRETAL. HISTOPATOLOGIA; CANCER COLORRETAL. IMAGEM; CANCER COLORRETAL. ESTADIAMENTO; CANCER COLORRETAL. TRATAMENTO; CANCER COLORRETAL. QUIMIOTERAPIA; CANCER COLORRETAL. RADIOTERAPIA; METASTASE HEPATICA. CIRURGIA; ESTOMAS

278/521US=65 / Biol/Mol
Christensen IJ, Pappot H, Hoyer-Hansen G. The plasminogen activation system as a source of prognostic markers in cancer. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 569-86. ISBN 978-0-387-69056-8.

SISTEMA DE ATIVACAO DO PLASMINOGENIO; MARCADORES; PROGNOSTICO NO CANCER; UPA; UPAR; PAI-1; CANCER DE MAMA; CANCER COLORRETAL; CANCER DE PULMAO; CANCER GINECOLOGICO; CANCER DE PROSTATA

279/521US=65 / Biol/Mol
Frederiksen C, Lomholt AF, Nielsen HJ, Brünner N. TIMP-1 as a prognostic marker in colorectal cancer. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 679-96. ISBN 978-0-387-69056-8.

CANCER COLORRETAL; MARCADOR DE PROGNOSTICO; TIMP-1

280/521US=67 / Biol/Mol
Sundermeyer ML, Bellacosa A, Meropol NJ. Molecular targeting of colorectal cancer: an idea whose time has come. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 117-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

CANCER COLORRETAL; SEGMENTACAO MOLECULAR; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR

Primeira | Anterior | Próxima | Última